721970-36-1 Usage
Uses
Used in Pharmaceutical Industry:
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid is used as an antibiotic agent for the treatment of various bacterial infections. Its ability to inhibit DNA gyrase makes it effective against a broad spectrum of bacteria, including both Gram-positive and Gram-negative organisms.
Used in Research and Development:
In addition to its clinical applications, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid is also used in research and development for the study of bacterial resistance mechanisms and the development of new antibiotics with improved efficacy and reduced side effects.
Used in Veterinary Medicine:
This complex antibiotic compound is also utilized in veterinary medicine for the treatment of bacterial infections in animals, ensuring the health and well-being of livestock and pets.
Overall, 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid is a versatile and potent antibiotic agent with applications in various industries, including human and veterinary medicine, as well as research and development. Its unique chemical structure and mechanism of action make it an important tool in the fight against bacterial infections.
Check Digit Verification of cas no
The CAS Registry Mumber 721970-36-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,1,9,7 and 0 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 721970-36:
(8*7)+(7*2)+(6*1)+(5*9)+(4*7)+(3*0)+(2*3)+(1*6)=161
161 % 10 = 1
So 721970-36-1 is a valid CAS Registry Number.
InChI:InChI=1/C20H22FN3O4/c21-14-6-12-16(24(11-3-4-11)8-13(18(12)25)20(27)28)19(26)17(14)23-7-10-2-1-5-22-15(10)9-23/h6,8,10-11,15,22,26H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1
721970-36-1Relevant academic research and scientific papers
Method for synthesizing moxifloxacin and derivatives thereof
-
Paragraph 0059-0062, (2019/10/01)
The invention provides a method for synthesizing moxifloxacin and derivatives thereof. Aminopyrrolidone derivatives are constructed to further obtain (S,S)-2,8-diazo-bicyclo[4.3.0]nonane so as to synthesize the moxifloxacin and the derivatives thereof. The method has the beneficial effects that raw materials are wide in source and low in price; chiral resolution is not needed in a preparation process; the yield and purity are relatively high; the process cost is further reduced; obvious economic value is achieved.
Moxifloxacin impurity C preparation method
-
Paragraph 0061; 0062; 0063; 0064, (2017/10/27)
The invention relates to a method for preparing Moxifloxacin impurity C. The method specifically comprises the steps of enabling a Moxifloxacin impurity E, which serves as a starting raw material, to be subjected to reaction of four steps, i.e., amino Boc protection, ethylation, esterolysis and Boc protection removal in all, and finally, carrying out recrystallization operation once, thereby obtaining the high-purity Moxifloxacin impurity C refined product. The method has the characteristics that the synthesis route is short, the operation is simple, the obtained impurity product is relatively high in purity and can be applied to reference research, and the like.
